Evidence Library
Filter by drug, type, year, and open access.
Showing 51–100 of 113 results
- Liraglutide for Prediabetes/Obesity in Clozapine- or Olanzapine-Treated Schizophrenia Spectrum Disorder (RCT) — JAMA Psychiatry (2017)• Drug: tirzepatide-zepboundOpen accessPMIDPMCID
- Olanzapine/fluoxetine for bipolar depression: randomized trials — RCTs (2016)• Drug: olanzapine
- Cariprazine in bipolar I depression: randomized controlled trial — American Journal of Psychiatry (2016)• Drug: cariprazineDOIPMID
- Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials — Biological Psychiatry (2016)• Drug: suvorexantDOIPMID
- Lisdexamfetamine dimesylate in binge eating disorder: a placebo controlled trial — Human Psychopharmacology (2016)• Drug: lisdexamfetaminePMID
- Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial — The Lancet (2016)• Drug: vareniclineDOIPMID
- Brexpiprazole for acute schizophrenia: 6-week randomized trial — Schizophrenia Research (2015)• Drug: brexpiprazoleDOIPMID
- Vortioxetine improves cognitive function in major depressive disorder (FOCUS study) — Neuropsychopharmacology (2015)• Drug: vortioxetineDOIPMID
- Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials — The Lancet (2015)• Drug: tasimelteonDOIPMID
- Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia: A Randomized Clinical Trial — JAMA Psychiatry (2015)• Drug: paliperidone-palmitateDOIPMID
- Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial — Lancet (2014)• Drug: pimavanserinPMID
- Desvenlafaxine versus placebo in major depressive disorder — BMC Psychiatry (2013)• Drug: desvenlafaxineOpen accessDOIPMCID
- Randomized, double-blind trial of guanfacine extended release in children with ADHD: morning or evening administration — Journal of the American Academy of Child and Adolescent Psychiatry (2013)• Drug: guanfacine-erPMID
- Pitolisant versus placebo or modafinil in patients with narcolepsy — Lancet Neurology (2013)• Drug: pitolisantDOIPMID
- Gabapentin enacarbil in Japanese patients with restless legs syndrome: a 12-week, randomized, double-blind, placebo-controlled, parallel-group study — Current Medical Research and Opinion (2012)• Drug: gabapentin-enacarbilDOI
- Doxepin 3 and 6 mg for chronic primary insomnia — Sleep (2011)• Drug: doxepinDOI
- Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD — Pediatrics (2011)• Drug: clonidine-erPMID
- Randomized trial of pramipexole for patients with restless legs syndrome (RLS) and RLS-related impairment of mood — Sleep Medicine (2011)• Drug: pramipexoleDOI
- Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial — The Lancet (2011)• Drug: naltrexone-extended-releaseDOIPMID
- Desvenlafaxine and escitalopram in postmenopausal women with MDD — Menopause (2010)• Drug: desvenlafaxineDOI
- A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder — American Journal on Addictions (2010)• Drug: atomoxetinePMID
- Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: a randomized, double-blind, placebo-controlled study — Schizophrenia Research (2010)• Drug: paliperidone-palmitateDOIPMID
- Asenapine for acute mania: randomized placebo-controlled trial — Bipolar Disorders (2009)• Drug: asenapineDOIPMID
- Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial — Progress in Neuro-Psychopharmacology & Biological Psychiatry (2009)• Drug: oxcarbazepineDOIPMID
- Efficacy and safety of iloperidone in acute schizophrenia — Schizophrenia Research (2008)• Drug: iloperidoneDOIPMID
- Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: placebo-controlled study — Biological Psychiatry (2008)• Drug: prazosinOpen accessDOIPMIDPMCID
- Long-term efficacy and safety of zolpidem extended-release 12.5 mg (6-month randomized, placebo-controlled trial) — Sleep (2008)• Drug: zolpidemOpen accessDOIPMIDPMCID
- Lifestyle Intervention and Metformin for Treatment of Antipsychotic-Induced Weight Gain — JAMA (2008)• Drug: metforminDOI
- Efficacy of duloxetine on cognition in elderly patients with MDD — American Journal of Psychiatry (2007)• Drug: duloxetineDOI
- Prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder: placebo-controlled study — Biological Psychiatry (2007)• Drug: prazosinDOIPMID
- Topiramate for Treating Alcohol Dependence: A Randomized Controlled Trial — JAMA (2007)• Drug: topiramateDOI
- Double-Blind, Randomized, Placebo-Controlled Trial of Topiramate Plus Cognitive-Behavior Therapy in Binge-Eating Disorder — Journal of Clinical Psychiatry (2007)• Drug: topiramateDOI
- Lamotrigine augmentation in treatment-resistant bipolar depression: a STEP-BD randomized trial — American Journal of Psychiatry (2006)• Drug: lamotrigineDOIPMID
- Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial — CNS Spectrums (2006)• Drug: amphetamine-dextroamphetaminePMID
- The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy — Current Medical Research and Opinion (2006)• Drug: armodafinilDOIPMID
- Sodium oxybate improves excessive daytime sleepiness in narcolepsy — Sleep (2006)• Drug: sodium-oxybateDOIPMID
- Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial — Journal of Clinical Psychiatry (2006)• Drug: selegiline-transdermalDOI
- Escitalopram versus citalopram in outpatient major depressive disorder — International Clinical Psychopharmacology (2005)• Drug: escitalopramDOI
- Effectiveness of antipsychotic drugs in patients with chronic schizophrenia — The New England Journal of Medicine (2005)• Drug: perphenazineDOIPMID
- Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome — Sleep Medicine (2005)• Drug: ropiniroleDOI
- Ziprasidone in the treatment of acute bipolar mania — American Journal of Psychiatry (2003)• Drug: ziprasidoneDOIPMID
- Sustained efficacy of eszopiclone over 6 months of nightly treatment: randomized, double-blind, placebo-controlled study in adults with chronic insomnia — Sleep (2003)• Drug: eszopicloneDOIPMID
- Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression — Archives of General Psychiatry (2003)• Drug: olanzapine-fluoxetinePMID
- Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial — Neurology (2002)• Drug: nortriptylineDOIPMID
- Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial — Journal of the American Academy of Child and Adolescent Psychiatry (2001)• Drug: fluvoxamineDOIPMID
- Randomized comparison of venlafaxine and sertraline in major depressive disorder — Journal of Clinical Psychiatry (2000)• Drug: venlafaxineDOIPMID
- Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial — JAMA (2000)• Drug: sertralineDOIPMID
- Zaleplon improves sleep without producing rebound effects in outpatients with insomnia — International Clinical Psychopharmacology (2000)• Drug: zaleplonDOIPMID
- Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial — Archives of General Psychiatry (1999)• Drug: phenelzineOpen accessDOIPMIDPMCID
- Treatment of Social Phobia With Gabapentin — Journal of Clinical Psychopharmacology (1999)• Drug: gabapentinDOI